Dyne therapeutics competitors
WebMar 20, 2024 · WALTHAM, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on … WebFind Dyne Therapeutics stock competitors. Compare other stocks that are similar to DYN in performance, different metrics, and ratios. ... Dyne Therapeutics (DYN) Similar …
Dyne therapeutics competitors
Did you know?
WebThe Competitors page allows you to view information for other symbols found in the same sector. In the table, you'll find all the components (individual stock symbols) found in that … WebMay 16, 2024 · About Dyne Therapeutics. Dyne Therapeutics is building a leading muscle disease company dedicated to advancing innovative life-transforming therapeutics for people living with genetically driven diseases. ... Sector and Competitors. 1st jan. Capi. (M$) DYNE THERAPEUTICS, INC.-26.40%: 497: MODERNA, INC.-13.39%: 59 996: …
WebNov 3, 2024 · Cash position: Cash, cash equivalents and marketable securities were $248.1 million as of September 30, 2024, which is anticipated to fund operations through 2024. Research and development (R&D) expenses: R&D expenses were $34.7 million for the quarter ended September 30, 2024, compared to $36.5 million for the quarter ended … WebModerna Inc. stock outperforms competitors on strong trading day. MRNA +3.87% COMP +1.97%. MarketWatch · 2 days ago. Analyst. ... Dyne Therapeutics Inc. is a muscle disease company. The Company ...
WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's email format. ... Dyne Therapeutics Top Competitors. Company Employees Revenue Top technologies; Akouos. 57: $19.2 M: Generation Bio. 106: $18.5 M: Leap Therapeutics. … WebDyne Therapeutics is a public company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Joshua Brumm. Its headquarters is located at Waltham, Massachusetts, USA. The number of employees ranges from 25 to …
WebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability ...
WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. DYN - Dyne Therapeutics Inc Stock quote - … diaper\u0027s f8WebMay 16, 2024 · DYNE-101 is designed to enable targeted delivery to muscle tissue and address the genetic basis of the disease. The new data being presented during ASGCT evaluated monthly repeat doses of DYNE-101 ... diaper\u0027s ofWebFind company research, competitor information, contact details & financial data for Dyne Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & … diaper\u0027s f6WebMar 30, 2024 · 85.5% of Dyne Therapeutics shares are held by institutional investors. 43.7% of Precigen shares are held by insiders. Comparatively, 42.3% of Dyne … diaper\u0027s owWebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's … citi business savingsWebMar 23, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … diaper\\u0027s thWebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by … citibusinesssystems.com